Company Filing History:

10 out of 512

Sloan-kettering Institute for Cancer Research

Cornell Research Foundation Inc.

patents

where one patent can have more than one assignee

Years Active: 1987-1999

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5928931 - Isolation, purification and cloning of retinol dehydratase (1999-07-27),

2. 5908868 - Retinol derivatives useful for enhancing immune response (1999-06-01),

3. 5883136 - Anhydroretinol and derivatives thereof as antagonists of immune (1999-03-16),

4. 5814612 - Retinol derivatives and uses thereof (1998-09-29),

5. 5648563 - Retro-alpha-retinol derivative and uses of retro-alpha-retinol (1997-07-15),

6. 5610200 - Anhydroretinol and derivatives thereof as antagonists of immune (1997-03-11),

7. 5521221 - Retro-.alpha.-retinol (4,14-retro-retinol) derivatives and uses of (1996-05-28),

8. 5358972 - Retro-alpha-retinol(4-14-retro-retinol) derivatives and uses of (1994-10-25),

9. 4804627 - Method for cloning lymphoblastoid cells (1989-02-14),

10. 4680258 - Process for sex determination in man by use of monoclonal antibodies to (1987-07-14),

Title: Ulrich Hammerling: Innovator in Biochemistry

Introduction

Ulrich Hammerling is a prominent inventor based in New York, NY (US), known for his significant contributions to the field of biochemistry. He holds a total of 10 patents, showcasing his innovative approach to scientific research and development.

Latest Patents

One of his latest patents focuses on the isolation, purification, and cloning of retinol dehydratase. This enzyme synthesizes the retro-retinoid anhydroretinol in the Spodoptera frugiperda insect cell line Sf-21. The invention includes the DNA molecule encoding the enzyme, which can be incorporated into a DNA expression system for recombinant production of anhydroretinol dehydratase. The isolated retinol dehydratase protein can be combined with a pharmaceutically acceptable carrier or used alone for administration to mammals, particularly humans, to prevent cell growth and uncontrolled cell growth in cells dependent on retinol and 14 hydroxy-4, 14-retro-retinol. Another patent involves retinol derivatives that are useful for enhancing immune response.

Career Highlights

Throughout his career, Ulrich Hammerling has worked with esteemed institutions such as the Sloan Kettering Institute for Cancer Research and Columbia University. His work has significantly impacted the understanding of biochemical processes and therapeutic applications.

Collaborations

He has collaborated with notable colleagues, including Jochen Buck and Fadila Derguini, contributing to various research projects and advancements in the field.

Conclusion

Ulrich Hammerling's innovative work in biochemistry and his numerous patents highlight his dedication to advancing scientific knowledge and therapeutic solutions. His contributions continue to influence the field and inspire future research endeavors.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.